Strain Information | |
---|---|
Image | |
BRC No. | RBRC05752 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129-Ttll10<tm1Seto> |
Former Common name | TTLL10 KO, B6-Ttll10 KO |
H-2 Haplotype | |
ES Cell line | RENKA [C57BL/6NCrlCrlj] |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Koji Ikegami and Mitsutoshi Setou, Medical Photonics Research Center, Hamamatsu University School of Medicine in 2008. The mutant mice were crossed to C57BL/6J. |
Strain description | Ttll10 gene knockout mice. A part of exon 2 to exon 6 were replaced with a neo cassette. |
Colony maintenance | Heterozygote x Wild-type [C57BL/6JJcl] |
References | TTLL10 is a protein polyglycylase that can modify nucleosome assembly protein 1. Ikegami K, Horigome D, Mukai M, Livnat I, MacGregor G R, Setou M FEBS Lett., 582, 1129-1134 (2008). 18331838 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Ttll10 MGI:1921855 | tubulin tyrosine ligase-like family, member 10 | 4 | Ttll10 <tm1Seto> | targeted mutation 1, Mitsutoshi Setou | |||
neo | neomycin resistance gene (E. coli) | 4 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | HSV thymidine kinase promoter, E. coli Neomycin resistance gene, HSV PolyA signal, mouse Ttll10 genomic DNA |
Research application | Cell Biology Research |
Specific Term and Conditions | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit institution for a not-for-profit research. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. The RECIPIENT must contact the DEPOSITOR prior to publishing the research results obtained by use of the BIOLOGICAL RESOURCE. The RECIPIENT must contact in advance the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. The RECIPIENT must not distribute the BIOLOGICAL RESOURCE and the derivatives to third parties. |
Depositor | Mitsutoshi Setou (Hamamatsu University School of Medicine) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |